HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Sasaki Selected Research

Type 2 Diabetes Mellitus (MODY)

3/2016Mixed-effects modelling to quantify the effect of empagliflozin on renal glucose reabsorption in patients with type 2 diabetes.
9/2003Acute hyposmia in type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Sasaki Research Topics

Disease

59Neoplasms (Cancer)
05/2017 - 01/2000
17Infections
06/2016 - 03/2000
16Stomach Neoplasms (Stomach Cancer)
10/2013 - 01/2000
14Neoplasm Metastasis (Metastasis)
01/2018 - 06/2000
12Carcinoma (Carcinomatosis)
01/2016 - 01/2000
10Breast Neoplasms (Breast Cancer)
05/2017 - 07/2000
6Inflammation (Inflammations)
10/2021 - 01/2001
6Pancreatic Neoplasms (Pancreatic Cancer)
04/2014 - 02/2000
5Colorectal Neoplasms (Colorectal Cancer)
03/2015 - 02/2000
5Colonic Neoplasms (Colon Cancer)
03/2005 - 02/2000
5Ischemia
01/2003 - 12/2000
5Lymphatic Metastasis
11/2002 - 01/2000
4Body Weight (Weight, Body)
01/2019 - 06/2001
4Thrombosis (Thrombus)
01/2017 - 04/2000
4Adenoma (Adenomas)
06/2012 - 01/2000
4Carcinogenesis
12/2005 - 03/2000
4Bone Resorption
06/2003 - 01/2000
4Biliary Atresia
06/2003 - 12/2000
3Rectal Neoplasms (Rectal Cancer)
01/2022 - 02/2015
3Hypoxia (Hypoxemia)
05/2017 - 01/2001
3Lung Neoplasms (Lung Cancer)
01/2017 - 06/2000
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2016 - 10/2014
3Prostatic Neoplasms (Prostate Cancer)
02/2016 - 01/2003
3Adenocarcinoma
03/2015 - 08/2000
3Neutropenia
07/2012 - 07/2001
3Pain (Aches)
06/2012 - 12/2000
3Hypertension (High Blood Pressure)
11/2010 - 06/2000
3Leukemia
04/2010 - 06/2000
3Aneurysm (Aneurysms)
07/2008 - 01/2000
3Seizures (Absence Seizure)
02/2008 - 02/2000
3Hemorrhage
12/2007 - 07/2000
3Wounds and Injuries (Trauma)
05/2006 - 12/2000
3Intracranial Vasospasm
01/2006 - 12/2001
3Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2006 - 02/2000
3Jaundice (Icterus)
06/2003 - 11/2000
3Graft vs Host Disease (Graft-Versus-Host Disease)
05/2003 - 01/2000
3Necrosis
01/2003 - 01/2000
3Pathologic Constriction (Stenosis)
09/2001 - 01/2000
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2001 - 06/2000
3Systemic Scleroderma (Systemic Sclerosis)
06/2001 - 11/2000
3Ureteral Obstruction
11/2000 - 02/2000
3Interstitial Lung Diseases (Interstitial Lung Disease)
11/2000 - 01/2000
2Tongue Neoplasms (Tongue Neoplasm)
07/2023 - 07/2001
2Melanoma (Melanoma, Malignant)
01/2017 - 03/2001
2Type 2 Diabetes Mellitus (MODY)
03/2016 - 09/2003
2Osteoarthritis
03/2015 - 02/2001
2Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary)
09/2014 - 05/2014
2Esophageal Neoplasms (Esophageal Cancer)
07/2014 - 01/2007

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
05/2017 - 01/2000
14Messenger RNA (mRNA)IBA
08/2009 - 02/2000
8EnzymesIBA
05/2006 - 01/2000
6Glucose (Dextrose)FDA LinkGeneric
03/2016 - 11/2000
5AntibodiesIBA
06/2016 - 05/2000
5Cisplatin (Platino)FDA LinkGeneric
10/2013 - 03/2000
5CytokinesIBA
12/2007 - 06/2001
5AntigensIBA
04/2002 - 11/2000
5Doxorubicin (Adriamycin)FDA LinkGeneric
12/2001 - 03/2000
4GemcitabineFDA Link
04/2014 - 08/2009
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2012 - 12/2000
4Complement System Proteins (Complement)IBA
11/2010 - 03/2000
4Indicators and Reagents (Reagents)IBA
09/2003 - 03/2000
4AutoantibodiesIBA
07/2001 - 11/2000
4DNA (Deoxyribonucleic Acid)IBA
06/2001 - 03/2000
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2001 - 04/2000
3Diphosphonates (Bisphosphonates)IBA
10/2023 - 01/2000
3Monoclonal AntibodiesIBA
01/2017 - 04/2001
3insulin degludecIBA
12/2016 - 10/2014
3Insulin Detemir (Levemir)FDA Link
12/2016 - 10/2014
3Neutralizing AntibodiesIBA
06/2016 - 03/2001
3Coloring Agents (Dyes)IBA
04/2015 - 12/2005
3Nonsense Codon (Nonsense Mutation)IBA
09/2014 - 04/2000
3CreatinineIBA
04/2011 - 08/2009
3Serum AlbuminIBA
04/2011 - 11/2000
3Carcinoembryonic AntigenIBA
08/2009 - 09/2001
3Phosphotransferases (Kinase)IBA
02/2008 - 08/2000
3Immunoglobulin G (IgG)IBA
12/2007 - 05/2000
3CalciumIBA
11/2007 - 02/2000
3RNA (Ribonucleic Acid)IBA
03/2007 - 09/2001
3NF-kappa B (NF-kB)IBA
07/2006 - 12/2001
3Glial Fibrillary Acidic ProteinIBA
09/2003 - 10/2001
3Fluorouracil (Carac)FDA LinkGeneric
04/2001 - 02/2000
3Cadherins (E-Cadherin)IBA
11/2000 - 03/2000
2CholesterolIBA
10/2021 - 03/2010
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2019 - 01/2003
2Matrix Metalloproteinase 14 (MT1-MMP)IBA
05/2017 - 01/2000
2Cell Adhesion MoleculesIBA
05/2017 - 11/2000
2Oxygen (Dioxygen)IBA
01/2017 - 06/2001
2Hemoglobins (Hemoglobin)IBA
01/2017 - 08/2009
2C-Reactive ProteinIBA
01/2017 - 08/2000
2Insulin Aspart (NovoLog)FDA Link
12/2016 - 10/2014

Therapy/Procedure

30Therapeutics
10/2023 - 02/2000
13Drug Therapy (Chemotherapy)
01/2016 - 01/2000
8Radiotherapy
07/2014 - 01/2000
6Transplantation
12/2003 - 01/2001
3Liver Transplantation
06/2003 - 02/2000
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
05/2003 - 01/2001
3Aftercare (After-Treatment)
10/2001 - 08/2000
3Hematopoietic Stem Cell Transplantation
10/2001 - 01/2000
2Lymph Node Excision (Lymph Node Dissection)
01/2022 - 11/2001
2Neoadjuvant Therapy
04/2015 - 08/2006